...
【24h】

Experimental small bowel transplantation using newborn intestine in rats: II. Revascularization of newborn intestine is independent of vascular endothelial growth factor.

机译:大鼠新生肠实验性小肠移植:II。新生肠的血运重建独立于血管内皮生长因子。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Fetal and newborn intestine often are revascularized after subcutaneous transplantation without surgical vascular anastomosis. However, the mechanism of this ability remains unclear. METHODS: First, the ability of natural revascularization in newborn organs was tested. Newborn organs in whole (liver, kidney, heart, intestine, spleen, and pancreas) were grafted i nto the subcuta neous tissue of the adult rat and evaluated histopathologically 2 weeks after transplantation. Second, expression of vascular endothelial growth factor (VEGF) mRNA in the intestinal graft was determined before and after transplantation. Finally, we tested whether the free graft survival of newborn intestine was interrupted by TNP-470, an antiangiogenic agent. RESULTS: Spleen and intestine were revascularized at a higher rate (91.6%, 75%, respectively), and kidney and heart grafts survived at a lower rate (41.7%, 25%, respectively). But all of liver and pancreas grafts failed to be revascularized. VEGF mRNA was not induced in the course of revascularizing. Furthermore, TNP-470 did not interfere with neovascularization of the newborn intestinal graft in vivo. CONCLUSIONS: Each organ had an organ-specific angiogenic activity. Neovascularization of intestinal graft was not dependent on VEGF expression.
机译:背景:皮下移植后,胎儿和新生肠通常在没有手术血管吻合的情况下进行血运重建。但是,这种能力的机制仍不清楚。方法:首先,对新生器官进行自然血管重建的能力进行了测试。将完整的新生器官(肝,肾,心脏,肠,脾和胰腺)移植到成年大鼠的皮下组织中,并在移植后2周进行组织病理学评估。其次,在移植前后确定肠移植物中血管内皮生长因子(VEGF)mRNA的表达。最后,我们测试了新生肠的游离移植物存活是否被抗血管生成剂TNP-470中断。结果:脾脏和肠的血运重建率较高(分别为91.6%,75%),肾脏和心脏移植物的存活率较低(分别为41.7%,25%)。但是所有的肝脏和胰腺移植物都无法进行血管重建。在血管重建过程中未诱导VEGF mRNA。此外,TNP-470不会在体内干扰新生肠移植的新血管形成。结论:每个器官都具有器官特异性血管生成活性。肠移植物的新血管形成不依赖于VEGF表达。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号